RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Evelo Biosciences Stock

Evelo Biosciences Liabilities 2025

Evelo Biosciences Liabilities

69.4 M USD

Ticker

EVLO

ISIN

US2997342025

WKN

A2JLXN

In 2025, Evelo Biosciences's total liabilities amounted to 69.4 M USD, a 0% difference from the 0 USD total liabilities in the previous year.

Evelo Biosciences Aktienanalyse

What does Evelo Biosciences do?

Evelo Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Evelo Biosciences's Liabilities

Evelo Biosciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Evelo Biosciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Evelo Biosciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Evelo Biosciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Evelo Biosciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Evelo Biosciences stock

What is the level of liabilities of Evelo Biosciences this year?

Evelo Biosciences has a debt balance of 69.4 M USD this year.

What were the liabilities of Evelo Biosciences compared to the previous year?

The liabilities of Evelo Biosciences have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Evelo Biosciences?

High liabilities can pose a risk for investors of Evelo Biosciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Evelo Biosciences?

Low liabilities mean that Evelo Biosciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Evelo Biosciences affect the company?

An increase in liabilities of Evelo Biosciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Evelo Biosciences affect the company?

A decrease in the liabilities of Evelo Biosciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Evelo Biosciences?

Some factors that can influence the liabilities of Evelo Biosciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Evelo Biosciences so important for investors?

The liabilities of Evelo Biosciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Evelo Biosciences take to modify the liabilities?

To change its liabilities, Evelo Biosciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Evelo Biosciences pay?

Over the past 12 months, Evelo Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evelo Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Evelo Biosciences?

The current dividend yield of Evelo Biosciences is .

When does Evelo Biosciences pay dividends?

Evelo Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evelo Biosciences?

Evelo Biosciences paid dividends every year for the past 0 years.

What is the dividend of Evelo Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evelo Biosciences located?

Evelo Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evelo Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evelo Biosciences from 2/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/3/2025.

When did Evelo Biosciences pay the last dividend?

The last dividend was paid out on 2/3/2025.

What was the dividend of Evelo Biosciences in the year 2024?

In the year 2024, Evelo Biosciences distributed 0 USD as dividends.

In which currency does Evelo Biosciences pay out the dividend?

The dividends of Evelo Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Evelo Biosciences

Our stock analysis for Evelo Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evelo Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.